Healthcare -
Biotechnology - NASDAQ - US
$ 1.9
-1.04 %
$ 398 M
Market Cap
-1.23
P/E
ALLO - LONG-TERM DEBT
Long-term Debt ALLO - Allogene Therapeutics, Inc.
88.3 M
LAST VALUE
12.40%
2 YEAR CAGR
20.72%
5 YEAR CAGR
0.00%
10 YEAR CAGR